CTKB

Cytek Biosciences, Inc.
$4.62
-0.16 (-3.35%)
Mkt Cap 596.64M
Volume 629,427
52W Range 3.28-6.18
Sector Healthcare
Beta 1.17
EPS (TTM) -0.62 USD
P/E Ratio -9.71
Revenue (TTM) 206.71M USD
Rev Growth (5Y) +16.8%
EPS Growth (5Y) N/A
AlphaQuality · Grade · Gated
How strong & durable the business is
F
Stable Earnings Power
30.0 / 100 pillar composite (overridden)
Steady, predictable earnings power — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019
Revenue 201.49M 200.45M 193.01M 164.04M 127.95M 92.84M 57.88M
Net Income (66.54M) (6.02M) (12.15M) 2.58M 3.00M 19.41M (16.83M)
EPS -0.52 -0.05 -0.09 0.02 0.03 0.02 -0.13
Free Cash Flow (8.77M) 21.85M 454,000 (22.10M) 266,000 13.61M (14.72M)
FCF / Share -0.07 0.17 0.00 -0.16 0.00 0.10 -0.11
Operating CF (4.69M) 25.38M 5.28M (12.23M) 4.63M 15.16M (13.75M)
Total Assets 461.54M 499.50M 494.46M 519.48M 463.31M 219.98M 70.36M
Total Debt 23.74M 17.02M 14.14M 18.09M 0 2.77M 0
Cash & Equiv 90.85M 98.72M 167.30M 296.60M 364.62M 165.23M 30.12M
Book Value 341.74M 395.74M 393.06M 425.30M 405.04M (16.03M) (41.70M)
Return on Equity -0.19 -0.02 -0.03 0.01 0.01 N/A N/A
CTKB News
Cytek Biosciences to Participate in Upcoming Investor Conferences
Sep 01, 2026 12:05 PM · globenewswire.com
Jury Finds in Cytek's Favor on Three of Four Asserted Claims; Company to Challenge Remaining Finding
Aug 21, 2026 12:35 PM · globenewswire.com
Cytek Biosciences, Inc. (CTKB) Q2 2026 Earnings Call Transcript
Aug 06, 2026 02:10 AM · seekingalpha.com
Cytek Biosciences Q2 Earnings Call Highlights
Aug 05, 2026 04:04 PM · marketbeat.com
Cytek Biosciences, Inc. (CTKB) Reports Q2 Loss, Tops Revenue Estimates
Aug 05, 2026 03:11 PM · zacks.com
Cytek Biosciences Reports Second Quarter 2026 Financial Results
Aug 05, 2026 12:05 PM · globenewswire.com
Analysts Estimate Cytek Biosciences, Inc. (CTKB) to Report a Decline in Earnings: What to Look Out for
Jul 29, 2026 07:06 AM · zacks.com
CSBR vs. CTKB: Which Life Sciences Stock Has Better Long-Term Upside?
Jul 23, 2026 10:21 AM · zacks.com
Cytek Biosciences to Report Second Quarter 2026 Financial Results on August 5, 2026
Jul 22, 2026 12:05 PM · globenewswire.com
Cytek® Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer Engagement
Jul 15, 2026 01:00 PM · globenewswire.com